| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| BI-3406 |
BI-3406 |
2230836-55-0 |
詳細(xì)
|
| MTRX-849 |
MRTX-849 |
2326521-71-3 |
詳細(xì)
|
| AMG 510 |
AMG510 單一構(gòu)型 |
2296729-00-3 |
詳細(xì)
|
| AMG 510 Racemate |
AMG-510(消旋體) |
2252403-56-6 |
詳細(xì)
|
| ARS 1620 |
CPD1588 |
1698055-85-4 |
詳細(xì)
|
| ARS-1630 |
ARS-1630 |
1698055-86-5 |
詳細(xì)
|
| KSQ-4279 |
KSQ-4279 |
2446480-97-1 |
詳細(xì)
|
| RTA 408; Omaveloxolone |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
詳細(xì)
|
| Bardoxolone methyl |
甲基巴多索隆 |
218600-53-4 |
詳細(xì)
|
| Bardoxolone |
2-氰基-3,12-二氧代齊墩果-1,9-二烯-28-酸 |
218600-44-3 |
詳細(xì)
|
| BGB-324; R428 |
R428 |
1037624-75-1 |
詳細(xì)
|
| KAT6-IN-1 |
N-(6-((1H-吡唑-1-基)甲基)-4-甲氧基苯并[D]異惡唑-3-基)-2-甲氧基苯磺酰胺 |
2569008-99-5 |
詳細(xì)
|
| Opevesostat |
/ |
2231294-96-3 |
詳細(xì)
|
| LX-4211; Sotagliflozin; LP-802034; |
索格列凈 |
1018899-04-1 |
詳細(xì)
|
| Ipragliflozin;Suglat;ASP-1941 |
伊格列凈 |
761423-87-4 |
詳細(xì)
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
詳細(xì)
|
| Batefenterol |
BATEFENTEROL |
743461-65-6 |
詳細(xì)
|
| BAR502 |
BAR 502 |
1612191-86-2 |
詳細(xì)
|
| BAR 501 |
CPDD0945 |
1632118-69-4 |
詳細(xì)
|
| BI-847325 |
BI-847325 |
1207293-36-4 |
詳細(xì)
|
| gSK-461364 |
GSK461364 |
929095-18-1 |
詳細(xì)
|
| MK3102 |
奧格列?。∕K-3102） |
1226781-44-7 |
詳細(xì)
|
| EW-7197 |
EW-7197 |
1352608-82-2 |
詳細(xì)
|
| Mirogabalin |
米洛巴林 |
1138245-13-2 |
詳細(xì)
|
| Mirogabalin besylate |
10928苯磺酸鹽 |
1138245-21-2 |
詳細(xì)
|
| ND-646 |
ACC抑制劑(ND-646) |
1434639-57-2 |
詳細(xì)
|
| ND-630 |
GS0976,ND-630 |
1434635-54-7 |
詳細(xì)
|
| Ingliforib |
CPD2802 |
186392-65-4 |
詳細(xì)
|
| Avapritinib; BLU-285 |
阿伐普替尼 |
1703793-34-3 |
詳細(xì)
|
| BI-3812 |
CPD1815 |
2166387-64-8 |
詳細(xì)
|
| E-7046,E7046 |
E-7046 |
1369489-71-3 |
詳細(xì)
|
| IPI-549 |
IPI-549 |
1693758-51-8 |
詳細(xì)
|
| A-966492 |
A-966492 |
934162-61-5 |
詳細(xì)
|
| GSK2256098 |
GSK-2256098 |
1224887-10-8 |
詳細(xì)
|
| Galloflavin |
培黃素 |
568-80-9 |
詳細(xì)
|
| NI-42 |
NI-42 |
1884640-99-6 |
詳細(xì)
|
| CP 94253 hydrochloride |
CP 94253鹽酸鹽 |
845861-39-4 |
詳細(xì)
|
| Givinostat (ITF2357) |
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽水合物 |
732302-99-7 |
詳細(xì)
|
| Fosifidancitinib |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
1237168-58-9 |
詳細(xì)
|
| DS-7423 |
DS 7423) |
1222104-37-1 |
詳細(xì)
|
| HQ461 |
HQ461 |
1226443-41-9 |
詳細(xì)
|
| EB-42486 |
化合物EB-42486 |
2390475-81-5 |
詳細(xì)
|
| BAY-6035 |
BAY-6035 |
2247890-13-5 |
詳細(xì)
|
| Sec61-IN-1 |
化合物SEC61-IN-1 |
2484865-42-9 |
詳細(xì)
|
| HS38 |
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide |
1030203-81-6 |
詳細(xì)
|
| Seliciclib |
細(xì)胞周期蛋白B激酶抑制劑 |
186692-46-6 |
詳細(xì)
|
| CDDO-Imidazolide, RTA-403, TP-235 |
CPD1598 |
443104-02-7 |
詳細(xì)
|
| CM 4620 |
CS-2907 |
1713240-67-5 |
詳細(xì)
|
| H3B-6527 |
H3B-6527 |
1702259-66-2 |
詳細(xì)
|
| RepSox (E-616452) |
2-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]-1,5-萘啶 |
446859-33-2 |
詳細(xì)
|
| A2A receptor antagonist 1 |
443103-97-7 |
443103-97-7 |
詳細(xì)
|
| PF-9363 |
PF-9363 |
2569009-58-9 |
詳細(xì)
|
| ALLOPREGNAN-3ALPHA-OL-20-ONE |
四氫孕酮 |
516-54-1 |
詳細(xì)
|
| JNJ-42226314 |
JNJ-42226314 |
1252765-13-1 |
詳細(xì)
|
| (S)-Amisulpride |
S-(-)-氨磺必利 |
71675-92-8 |
詳細(xì)
|
| 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde |
1,3-二甲基尿嘧啶-5-甲醛 |
4869-46-9 |
詳細(xì)
|
| 4,6-DICHLORO-2-[(2,3-DIFLUOROBENZYL)THIO]PYRIMIDINE |
4,6-二氯-2-((2,3-二氟苯甲基)硫代)嘧啶 |
654073-29-7 |
詳細(xì)
|
| ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone |
(5S)-4,5-O-(1-甲基亞乙基)-1-C-4-嗎啉基-D-戊二醛-5,2-呋喃木糖 |
1103738-19-7 |
詳細(xì)
|
| (S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-amine |
CPD3615-A5 |
2045894-03-7 |
詳細(xì)
|
| Name: 8,9-dihydro-5H-benzo[
7]annulen-7(6H)-one |
5,6,8,9-四氫-苯并環(huán)庚烯-7-酮 |
37949-03-4 |
詳細(xì)
|
| 2,6-dichloro-3,5-dimethoxyaniline |
2,6-二氯-3,5-二甲氧基苯胺 |
872509-56-3 |
詳細(xì)
|
| 3-fluoro-N-methoxy-N-methyl-4-nitrobenzamide |
863604-64-2 |
863604-64-2 |
詳細(xì)
|
| methyl 3-hydroxy-5-nitrothiophene-2-carboxylate |
3-羥基-5-硝基噻吩-2-羧酸甲酯 |
89380-77-8 |
詳細(xì)
|
| methyl 3-hydroxythiophene-2-carboxylate |
3-羥基-2-噻吩甲酸甲酯 |
5118-06-9 |
詳細(xì)
|
| Tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate |
MK-3102 中間體1 |
951127-25-6 |
詳細(xì)
|
| 4-methoxybenzo[d]thiazol-2(3H)-one |
4-甲氧基-2(3H)-苯并噻唑酮 |
80567-66-4 |
詳細(xì)
|
| piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
哌啶-4-基 [1,1-聯(lián)苯]-2-氨基甲酸酯 |
171722-92-2 |
詳細(xì)
|
| di-tert-butyl 4-bromo-2-nitrophenylcarbamate |
二叔丁基(4-溴-2-硝基苯基)亞氨基二碳酸酯 |
1228392-59-3 |
詳細(xì)
|
| (R)-6-(benzyloxy)-8-(oxiran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one |
8-(2R)-環(huán)氧乙烷基-6-(芐氧基)-2H-1,4-苯并惡嗪-3(4H)-酮 |
869478-12-6 |
詳細(xì)
|
| 8-acetyl-6-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one |
6-(芐氧基)-8-乙?；?2H-苯并[1,4]惡嗪-3(4H)-酮 |
869478-09-1 |
詳細(xì)
|
| tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate |
MK-3102中間體 |
1172623-98-1 |
詳細(xì)
|
| Tert-butyl (1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-yl)carbamate |
[1-(2,5-二氟苯基)-1-氧代-4-戊炔-2-基]氨基甲酸叔丁酯 |
1172623-96-9 |
詳細(xì)
|
| Tert-butyl (1-(methoxy(methyl)amino)-1-oxopent-4-yn-2-yl)carbamate |
1-(甲氧基(甲基)氨基)-1-氧代-4-戊炔-2-氨基甲酸叔丁酯 |
1172623-95-8 |
詳細(xì)
|
| 6-iodo-[1,2,4]triazolo[1,5-a]pyridine |
6-碘-[1,2,4]三唑并[1,5-A]吡啶 |
614750-84-4 |
詳細(xì)
|
| 4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-5-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOLE-2-CARBALDEHYDE |
4-([1,2,4]三唑酮[1,5-a]吡啶-6-基)-5-(6-甲基吡啶-2-基)-1H-咪唑-2-甲醛 |
1352609-91-6 |
詳細(xì)
|
| tert-butyl 4-(7-bromo-6-chloro-8-fluoroquinazolin-4-yl)piperazine-1-carboxylate |
1588-A4 |
1698027-20-1 |
詳細(xì)
|
| 1-amino-2-naphthonitrile |
1-氨基-2-氰基萘 |
3100-67-2 |
詳細(xì)
|
| N-(2-chloro-4-formyl-5-methoxyphenyl)acrylamide |
N-(2-chloro-4-formyl-5-methoxyphenyl)acrylamide |
1251456-87-7 |
詳細(xì)
|
| {2-[(6-Methylpyridin-2-yl)amino]-1,3-thiazol-4-yl}acetic acid |
2-(2-((6-甲基吡啶-2-基)氨基)噻唑-4-基)乙酸 |
1283109-29-4 |
詳細(xì)
|